Northern Trust Corp Frequency Therapeutics, Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.44 - $5.47 $302 - $3,763	-688 Reduced 1.13%	59,972 $29,000
Q2 2022 Aug 12, 2022	SELL	$1.03 - $2.03 $218,684 - $430,999	-212,315 Reduced 77.78%	60,660 $91,000
Q1 2022 May 13, 2022	SELL	$1.7 - $5.72 $23,568 - $79,302	-13,864 Reduced 4.83%	272,975 $579,000
Q4 2021 Feb 08, 2022	SELL	$4.95 - $7.11 $413,428 - $593,834	-83,521 Reduced 22.55%	286,839 $1.47 Million
Q3 2021 Nov 15, 2021	BUY	$6.96 - $9.25 $338,784 - $450,253	48,676 Added 15.13%	370,360 $2.61 Million
Q2 2021 Aug 13, 2021	SELL	$8.05 - $11.61 $322,829 - $465,595	-40,103 Reduced 11.08%	321,684 $3.21 Million
Q1 2021 May 12, 2021	BUY	$7.99 - $55.01 $370,536 - $2.55 Million	46,375 Added 14.7%	361,787 $3.44 Million
Q4 2020 Feb 11, 2021	SELL	$18.65 - $40.0 $40,712 - $87,320	-2,183 Reduced 0.69%	315,412 $11.1 Million
Q3 2020 Nov 16, 2020	BUY	$17.76 - $24.96 $48,928 - $68,764	2,755 Added 0.88%	317,595 $6.1 Million
Q2 2020 Aug 14, 2020	BUY	$14.65 - $24.9 $3.48 Million - $5.91 Million	237,295 Added 306.01%	314,840 $7.32 Million
Q1 2020 May 14, 2020	BUY	$16.36 - $27.55 $53,399 - $89,923	3,264 Added 4.39%	77,545 $1.38 Million
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $941,140 - $1.39 Million	74,281 New	74,281 $1.3 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.